Network Bio (Series A)
Funding Details
Awarder
Inbox
Date Award
August 20, 2026
Vertical
Biotechnology
Funding Amount
$50,000,000
Company Info
Market
Personalized medicine
Location
Palo Alto, CA, USA
Coinvestors
Blue Venture Fund, Breyer Capital, Founders Fund, JSL Health Capital, Section 32, Thiel Bio
Company Description

Network Bio is a biotechnology company building disease-specific AI models from human biological data to support the personalized practice of medicine. Through collaborations with U.S.-based academic medical centers, the company has connected data spanning immunology, metabolic, cardiovascular, auto-immune disease, among others. By integrating this biological foundation with AI purpose-built for medicine, Network Bio is developing technologies designed to accelerate diagnostics, biomarker discovery and drug development.

Links